Results 151 to 160 of about 1,118 (162)

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

Lancet, The, 2016
Cj Chen, Oscar H Franco
exaly  

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Lancet, The, 2019
Hertzel C Gerstein, Gilles R Dagenais, Jeffrey Probstfield   +2 more
exaly  

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Lancet, The, 2010
Erik Ingelsson, Naveed Sattar
exaly  

Type 2 diabetes as an inflammatory disease

Nature Reviews Immunology, 2011
Marc Y Donath, Steven E Shoelson
exaly  

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

Lancet, The, 2011
Goodarz Danaei, Mariel M Finucane, Farshad Farzadfar   +2 more
exaly  

Targeting the pancreatic β-cell to treat diabetes

Nature Reviews Drug Discovery, 2014
Amedeo Vetere, Amit Choudhary, Bridget K Wagner   +2 more
exaly  

ANDROGEN DEPRIVATION RAISES RISK OF DIABETES, HEART DISEASE

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial

Lancet, The, 2018
Naomi Brosnahan, George Thom, Louise Mccombie   +2 more
exaly  

Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes

Nature Reviews Drug Discovery, 2009
Bo Ahrén
exaly  

SGLT2 inhibition — a novel strategy for diabetes treatment

Nature Reviews Drug Discovery, 2010
exaly